Literature DB >> 15231620

Antidepressants and suicide: what is the balance of benefit and harm.

David Gunnell1, Deborah Ashby.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15231620      PMCID： PMC443451          DOI： 10.1136/bmj.329.7456.34

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  28 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

2.  Emergence of intense suicidal preoccupation during fluoxetine treatment.

Authors:  M H Teicher; C Glod; J O Cole
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

3.  Suicidal ideation related to fluoxetine treatment.

Authors:  P Masand; S Gupta; M Dewan
Journal:  N Engl J Med       Date:  1991-02-07       Impact factor: 91.245

4.  Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicide.

Authors:  N Freemantle; A House; F Song; J M Mason; T A Sheldon
Journal:  BMJ       Date:  1994-07-23

5.  Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression.

Authors:  W Rutz; L von Knorring; J Wålinder
Journal:  Acta Psychiatr Scand       Date:  1992-01       Impact factor: 6.392

Review 6.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

Authors:  Craig J Whittington; Tim Kendall; Peter Fonagy; David Cottrell; Andrew Cotgrove; Ellen Boddington
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

7.  Antidepressants and public health in Iceland. Time series analysis of national data.

Authors:  Tómas Helgason; Helgi Tómasson; Tómas Zoega
Journal:  Br J Psychiatry       Date:  2004-02       Impact factor: 9.319

8.  Antidepressants and suicide.

Authors:  S S Jick; A D Dean; H Jick
Journal:  BMJ       Date:  1995-01-28

9.  Deliberate self-harm in adolescents: a study of characteristics and trends in Oxford, 1990-2000.

Authors:  Keith Hawton; Stephanie Hall; Sue Simkin; Liz Bale; Alison Bond; Sharon Codd; Anne Stewart
Journal:  J Child Psychol Psychiatry       Date:  2003-11       Impact factor: 8.982

10.  Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression.

Authors:  C M Beasley; B E Dornseif; J C Bosomworth; M E Sayler; A H Rampey; J H Heiligenstein; V L Thompson; D J Murphy; D N Masica
Journal:  BMJ       Date:  1991-09-21
View more
  29 in total

1.  Antidepressants and suicide: rising prescription rate does not mean rising rate of new users.

Authors:  Graham Aldred; David Healy
Journal:  BMJ       Date:  2004-08-21

2.  Antidepressants and suicide: risk of completed suicide is not the same as risk of deliberate self harm.

Authors:  Alex J Mitchell
Journal:  BMJ       Date:  2004-08-21

3.  Selective serotonin reuptake inhibitors.

Authors:  John R Geddes; Andrea Cipriani
Journal:  BMJ       Date:  2004-10-09

4.  Opportunity cost of antidepressant prescribing in England: analysis of routine data.

Authors:  Sandra Hollinghurst; David Kessler; Tim J Peters; David Gunnell
Journal:  BMJ       Date:  2005-03-18

Review 5.  Antidepressants and suicidality.

Authors:  Ulrich Hegerl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-06       Impact factor: 5.270

6.  Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001-2004.

Authors:  Richard M Martin; Margaret May; David Gunnell
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

7.  The p4 screener: evaluation of a brief measure for assessing potential suicide risk in 2 randomized effectiveness trials of primary care and oncology patients.

Authors:  Priyanka Dube; Kroenke Kurt; Matthew J Bair; Dale Theobald; Linda S Williams
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

Review 8.  [Antidepressants and suicidality. Risk-benefit analysis].

Authors:  U Hegerl
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

9.  The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study.

Authors:  Benedict W Wheeler; David Gunnell; Chris Metcalfe; Peter Stephens; Richard M Martin
Journal:  BMJ       Date:  2008-02-14

Review 10.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.